Community Health Systems Inc (CYH) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	-$0.1	-$0.19	-90.0%	—	$2.8B	—
Q1 26	-$0.09	-$0.48	-433.3%	—	$3B	—
Q3 25	-$0.28	$1.27	+553.6%	—	$3.1B	—
Q2 25	-$0.1	-$0.05	+50.0%	—	$3.1B	—
Q1 25	-$0.1	-$0.03	+70.0%	—	$3.2B	—
Q4 24	-$0.05	-$0.42	-740.0%	—	$3.3B	—
Q3 24	-$0.21	-$0.3	-42.9%	—	$3.1B	—
Q2 24	-$0.12	-$0.17	-41.7%	—	$3.1B	—
Q1 24	-$0.14	-$0.14	0.0%	—	$3.1B	—
Q4 23	$0.04	-$0.41	-1125.0%	—	$3.2B	—
Q3 23	-$0.18	-$0.33	-83.3%	—	$3.1B	—
Q2 23	-$0.27	-$0.22	+18.5%	—	$3.1B	—
Q1 23	-$0.16	-$0.43	-168.8%	—	$3.1B	—
Q4 22	$0.37	$1.5	+305.4%	—	$3.1B	—
Q3 22	-$0.05	-$0.52	-940.0%	—	$3B	—
Q2 22	$0.04	-$2.52	-6400.0%	—	$2.9B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$3.81	—	—	$12.5B	—
FY24	—	-$3.9	—	—	$12.6B	—
FY23	—	-$1.02	—	—	$12.5B	—
FY22	—	$0.35	—	—	$12.2B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$18.4B	$15.4B	$14.2B	$13.2B	$11.8B	$12.4B	$12.2B	$12.5B	$12.6B	$12.5B
YoY change	-5.14%	-16.7%	-7.8%	-6.68%	-10.8%	+4.91%	-1.27%	+2.28%	+1.15%	-1.18%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	18.4B	15.4B	14.2B	13.2B	11.8B	12.4B	12.2B	12.5B	12.6B	12.5B
Cost of revenue	11.6B	10B	8.7B	8.1B	7.4B	7.3B	7.3B	7.4B	1.9B	1.9B
Gross profit	6.8B	5.3B	5.4B	5.1B	4.4B	5.1B	4.9B	5.1B	10.7B	10.6B
Gross margin	36.9%	34.6%	38.3%	38.7%	37.5%	41.1%	40.2%	40.7%	84.6%	85.1%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	450M	394M	337M	321M	327M	308M	317M	319M	5.7B	5.7B
Operating expenses	4.6B	4.2B	3.8B	3.6B	3.3B	3.3B	3.7B	3.7B	9.4B	9.1B
Operating income	1.1B	214M	887M	881M	573M	1.3B	719M	870M	843M	1.1B
Operating margin	5.83%	1.39%	6.27%	6.67%	4.86%	10.3%	5.89%	6.97%	6.67%	8.67%
Non-operating income, net	-1.8B	-2.1B	-626M	-270M	880M	106M	488M	167M	-266M	512M
Pretax income	-1.7B	-2.8B	-715M	-430M	422M	499M	349M	207M	-283M	724M
Income tax	-104M	-449M	-11M	160M	-185M	131M	170M	191M	79M	48M
Net income	-1.6B	-2.4B	-704M	-590M	607M	368M	179M	16M	-362M	676M
Net margin	-8.82%	-15.6%	-4.97%	-4.47%	5.15%	2.98%	1.47%	0.13%	-2.87%	5.41%
EBITDA	2.2B	1.1B	1.6B	1.5B	1.1B	1.8B	1.4B	1.4B	1.3B	1.5B
EPS	-15.5	-22	-6.99	-5.93	4.43	1.82	0.35	-1.02	-3.9	3.81
Diluted EPS	-15.5	-22	-6.99	-5.93	4.39	1.76	0.35	-1.02	-3.9	3.77

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	3.1B	3.2B	3.1B	3.1B	3.1B	3.3B	3.2B	3.1B	3.1B	3.1B	3B	2.8B
Cost of revenue	1.8B	1.9B	1.9B	483M	469M	507M	489M	469M	460M	446M	441M	401M
Gross profit	1.3B	1.3B	1.3B	2.7B	2.6B	2.8B	2.7B	2.7B	2.6B	2.7B	2.5B	2.4B
Gross margin	40.8%	41.3%	40.9%	84.6%	84.8%	84.5%	84.5%	85%	85.1%	85.6%	85.1%	85.8%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	79M	79M	77M	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.4B	1.3B
Operating expenses	932M	943M	922M	2.3B	2.4B	2.3B	2.3B	2.3B	2.3B	2.3B	2.2B	2.1B
Operating income	199M	249M	248M	248M	62M	285M	260M	273M	264M	286M	191M	217M
Operating margin	6.45%	7.83%	7.9%	7.9%	2.01%	8.73%	8.23%	8.71%	8.55%	9.21%	6.44%	7.68%
Non-operating income, net	-24M	153M	-15M	18M	-265M	-4M	26M	379M	-50M	156M	86M	169M
Pretax income	-33M	193M	22M	50M	-419M	64M	67M	438M	-2M	221M	64M	180M
Income tax	19M	107M	28M	24M	-64M	92M	42M	118M	-173M	61M	89M	76M
Net income	-52M	86M	-6M	26M	-355M	-28M	25M	320M	171M	160M	-25M	104M
Net margin	-1.69%	2.7%	-0.19%	0.83%	-11.5%	-0.86%	0.79%	10.2%	5.54%	5.15%	-0.84%	3.68%
EBITDA	330M	375M	365M	376M	181M	420M	367M	381M	376M	397M	309M	327M
EPS	-0.69	0.35	-0.32	-0.1	-2.95	-0.53	-0.1	2.11	0.97	0.82	-0.43	0.51
Diluted EPS	-0.69	0.35	-0.32	-0.1	-2.95	-0.53	-0.1	2.09	0.96	0.81	-0.43	0.51

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	620.5M	477.1M	318.7M	330.6M	854.5M	—	557.3M	406.9M	394.7M	416.7M	407.5M
Enterprise value	15.6B	13.8B	13.7B	14.1B	12.1B	—	12.8B	12.5B	12.5B	11.2B	11B
Shares outstanding	111M	112M	113M	114M	115M	127M	129M	130M	132M	133.6M	133.6M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	—	—	—	—	1.41	—	3.11	25.4	—	0.62	1.63
P/S	0.03	0.03	0.02	0.03	0.07	—	0.05	0.03	0.03	0.03	0.03
P/B	0.27	-2.89	-0.33	-0.2	-0.81	—	-0.76	-0.49	-0.3	-0.5	-0.46
EV/EBITDA	7	12.5	8.49	9.38	10.5	—	9.24	9.06	9.28	7.37	8.26
EV/Sales	0.85	0.9	0.97	1.07	1.02	—	1.05	1	0.99	0.9	0.92
Earnings yield	—	—	—	—	71%	—	32.1%	3.93%	—	162.2%	61.2%
FCF yield	63.3%	43.8%	-79.4%	-16%	203.4%	—	-20.6%	-63.2%	30.4%	49.9%	48.4%
PEG	—	—	—	—	—	—	—	—	—	—	-0.02

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	36.9%	34.6%	38.3%	38.7%	37.5%	41.1%	40.2%	40.7%	84.6%	85.1%	85.8%
Operating margin	5.83%	1.39%	6.27%	6.67%	4.86%	10.3%	5.89%	6.97%	6.67%	8.67%	7.68%
Net margin	-8.82%	-15.6%	-4.97%	-4.47%	5.15%	2.98%	1.47%	0.13%	-2.87%	5.41%	2.1%
ROE	-71.3%	1.5K%	73.4%	36%	-57.6%	-45.4%	-24.4%	-1.94%	27.5%	-80.8%	-60.8%
ROA	-7.41%	-13.7%	-4.44%	-3.78%	3.79%	2.42%	1.22%	0.11%	-2.58%	5.12%	4.63%
ROIC	6.22%	1.62%	7.13%	7.24%	5.64%	8.19%	3.2%	0.59%	7.84%	10.2%	9.21%
Return on tangible assets	-18.3%	-29.9%	-10.4%	-8.49%	8.02%	5.43%	2.82%	0.24%	-5.59%	10.3%	7.17%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.62	1.73	1.48	1.5	1.6	1.47	1.41	1.5	1.41	1.46	1.53
Quick ratio	1.45	1.54	1.32	1.35	1.48	1.32	1.25	1.34	1.27	1.32	1.39
Debt / equity	6.68	-84.3	-14.2	-8.56	-12.2	-15.8	-16.9	-14.8	-9.19	-13.2	-0.12
Debt / assets	0.69	0.8	0.86	0.9	0.8	0.84	0.84	0.84	0.86	0.84	0.84
Net debt / EBITDA	6.72	12.1	8.29	9.17	9.8	6.68	8.84	8.76	8.99	7.1	7.14
Interest coverage	-0.76	-2.01	0.27	0.59	1.41	1.56	1.41	1.25	0.67	1.83	1.54
Effective tax rate	0%	0%	0%	0%	0%	26.3%	48.7%	92.3%	0%	6.63%	11.4%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	166.1	137.1	125.3	115.9	102.5	97.4	94.7	96.1	95.7	93.5	89.2
EPS (basic)	-15.5	-22	-6.99	-5.93	4.43	1.82	0.35	-1.02	-3.9	3.81	3.81
EPS (diluted)	-15.5	-22	-6.99	-5.93	4.39	1.76	0.35	-1.02	-3.9	3.77	1.77
Book value per share	20.6	-1.47	-8.49	-14.4	-9.17	-6.38	-5.69	-6.34	-9.98	-6.27	-10.3
FCF per share	3.54	1.87	-2.24	-0.46	15.1	-4.72	-0.89	-1.98	0.91	1.56	-1.36
Cash per share	2.14	5.03	1.73	1.89	14.6	3.99	0.91	0.29	0.28	1.95	1.1
Capex per share	6.57	4.97	4.59	3.82	3.79	3.61	2.92	3.38	2.69	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	3.95%	3.63%	3.67%	3.29%	3.7%	3.71%	3.09%	3.51%	2.81%	—	—
Capex / operating cash flow	-84.5%	-38%	-98.7%	1.2K%	18.3%	-210.6%	62.7%	119%	174%	—	—
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%

Yield

—

trailing twelve months

Frequency

—

Last dividend

$0.2066

ex-dividend Dec 13, 2012

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Dec 13, 2012	$0.2066

Split history

Date	Ratio
Apr 22, 2016	121:100

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$3.1B	$3.2B	$3.1B	$3.1B	$3.1B	$3.3B	$3.2B	$3.1B	$3.1B	$3.1B	$3B	$2.8B
YoY change	+2.02%	+1.27%	+1.03%	+0.8%	+0.13%	+2.61%	+0.61%	-0.22%	-0.1%	-4.87%	-6.14%	-9.83%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	238M	563M	196M	216M	1.7B	507M	118M	38M	37M	260M
Receivables	3.2B	2.4B	2.4B	2.3B	1.9B	2.1B	2B	2.2B	2.3B	2.1B
Inventory	480M	444M	402M	354M	335M	355M	353M	328M	331M	322M
Total current assets	4.7B	4.1B	3.5B	3.4B	4.5B	3.5B	3.1B	3.2B	3.3B	3.2B
Property, plant & equipment	711M	81M	-89M	-270M	-427M	-497M	-673M	-744M	-882M	-950M
Goodwill & intangibles	13B	9.4B	9.1B	8.7B	8.4B	8.4B	8.3B	7.9B	7.6B	6.6B
Total assets	21.9B	17.4B	15.9B	15.6B	16B	15.2B	14.7B	14.5B	14.1B	13.2B
Accounts payable	995M	967M	887M	811M	783M	830M	773M	912M	913M	842M
Short-term debt	455M	33M	204M	156M	265M	178M	169M	145M	135M	126M
Total current liabilities	2.9B	2.4B	2.4B	2.3B	2.8B	2.4B	2.2B	2.1B	2.3B	2.2B
Long-term debt	14.8B	13.9B	13.4B	13.9B	12.6B	12.6B	12.2B	12B	12B	10.9B
Total liabilities	19.7B	17.6B	16.8B	17.2B	17.1B	16B	15.4B	15.3B	15.4B	14B
Shareholders' equity	2.3B	-165M	-959M	-1.6B	-1.1B	-810M	-734M	-824M	-1.3B	-837M
Total debt	15.2B	13.9B	13.6B	14B	12.9B	12.8B	12.4B	12.2B	12.1B	11B
Net debt	15B	13.3B	13.4B	13.8B	11.2B	12.3B	12.3B	12.1B	12.1B	10.8B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	91M	38M	48M	39M	33M	37M	431M	456M	123M	260M	712M	149M
Receivables	2.2B	2.2B	2.2B	2.2B	2B	2.3B	2.3B	2.3B	2.2B	2.1B	2.1B	2.1B
Inventory	325M	328M	329M	337M	311M	331M	328M	326M	325M	322M	275M	271M
Total current assets	3.2B	3.2B	3.2B	3.2B	3.1B	3.3B	3.4B	3.7B	3.2B	3.2B	3.8B	3.1B
Property, plant & equipment	-4.2B	-744M	-4.4B	-4.4B	-4.1B	-882M	-4.5B	-4.4B	-4.4B	-950M	-3.9B	-3.9B
Goodwill & intangibles	7.9B	7.9B	7.9B	7.9B	7.9B	7.6B	7.6B	7.2B	7.1B	6.6B	6.3B	6.5B
Total assets	14.7B	14.5B	14.4B	14.4B	13.9B	14.1B	13.9B	13.6B	13.2B	13.2B	13.2B	12.2B
Accounts payable	837M	912M	941M	896M	842M	913M	974M	970M	894M	842M	790M	713M
Short-term debt	143M	145M	149M	141M	133M	135M	141M	135M	126M	126M	126M	126M
Total current liabilities	2.1B	2.1B	2.1B	2.2B	2.1B	2.3B	2.4B	2.3B	2.2B	2.2B	2.6B	2B
Long-term debt	12.4B	12B	12.1B	12B	12B	12B	11.8B	11.4B	11.1B	10.9B	10.6B	10.1B
Total liabilities	15.6B	15.3B	15.3B	15.3B	15.2B	15.4B	15.2B	14.7B	14.2B	14B	14.1B	13B
Shareholders' equity	-893M	-824M	-878M	-879M	-1.3B	-1.3B	-1.3B	-1.1B	-951M	-837M	-965M	-844M
Total debt	12.5B	12.2B	12.2B	12.2B	12.1B	12.1B	12B	11.5B	11.2B	11B	10.8B	10.2B
Net debt	12.4B	12.1B	12.2B	12.1B	12.1B	12.1B	11.5B	11B	11.1B	10.8B	10B	10.1B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	-1.6B	-2.4B	-704M	-590M	607M	368M	179M	16M	-362M	676M
Depreciation & amortization	1.1B	861M	700M	608M	558M	540M	534M	505M	486M	426M
Stock-based compensation	46M	24M	13M	10M	13M	25M	20M	22M	17M	11M
Change in working capital	-314M	456M	-315M	-428M	1.3B	-279M	-479M	-390M	-9M	3M
Operating cash flow	-863M	-1.5B	-526M	36M	2.4B	-218M	601M	369M	204M	543M
Capital expenditure	-729M	-557M	-519M	-435M	-436M	-459M	-377M	-439M	-355M	—
Investing cash flow	-589M	1.1B	-245M	-2M	177M	-524M	-259M	-26M	-275M	1.2B
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	-6M	-5M	-1M	-1M	-1M	-5M	-8M	-4M	-1M	—
Financing cash flow	-1.7B	-1.5B	-396M	-363M	-895M	-514M	-430M	-264M	-206M	-1.2B
Net change in cash	-3.2B	-1.9B	-1.2B	-329M	1.7B	-1.3B	-88M	79M	-277M	552M
Free cash flow	393M	209M	-253M	-53M	1.7B	-600M	-115M	-257M	120M	208M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	-52M	86M	-6M	26M	-354M	-28M	25M	320M	171M	160M	-25M	104M
Depreciation & amortization	129M	121M	115M	126M	116M	129M	105M	106M	106M	109M	114M	108M
Stock-based compensation	6M	6M	6M	2M	4M	5M	4M	3M	0	4M	3M	2M
Change in working capital	-247M	-104M	-55M	-7M	9M	44M	-9M	-92M	12M	92M	-347M	124M
Operating cash flow	-127M	171M	79M	205M	-289M	209M	144M	419M	69M	266M	-297M	88M
Capital expenditure	-127M	-109M	-92M	-85M	-69M	-109M	-85M	-86M	—	—	—	—
Investing cash flow	-101M	180M	-99M	-108M	75M	-143M	444M	342M	-19M	236M	1.1B	53M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	0	0	-2M	0	0	1M	—	—	—	—	—	—
Financing cash flow	45M	-323M	13M	-1.9B	-148M	2.6B	-169M	-2.6B	-321M	-271M	-272M	-1.3B
Net change in cash	-183M	28M	-7M	-1.8B	-362M	2.7B	419M	-1.8B	-271M	231M	530M	-1.2B
Free cash flow	-101M	-20M	3M	13M	-3M	107M	35M	-3M	4M	172M	-373M	12M

Community Health Systems Inc Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Split history

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement